Knowing how to use ipamorelin correctly matters more than the peptide itself. TelosRX covers the protocol basics — dosage ranges, injection timing, cycling approaches, and what to watch for — subject to medical approval by a licensed provider.
Ipamorelin is a growth hormone secretagogue (GHS). It prompts your pituitary gland to release growth hormone in natural pulses, rather than flooding your system with synthetic GH. It's highly selective — it triggers GH release without significantly raising cortisol or prolactin, which sets it apart from many other compounds in its class.
It's also not FDA-approved. Ipamorelin is a compounded research peptide, available at TelosRX following provider evaluation and review — not available over the counter or without a provider-issued prescription.
Step 1: Get Provider Approval Before Starting
Ipamorelin isn't a supplement you pick up at a health food store. It's a prescription compounded peptide, and starting without provider evaluation skips the safety steps that matter.
A licensed provider reviews your health history, current medications, and goals before approving any protocol. At TelosRX, this happens asynchronously — you submit your intake, a provider reviews it, and you receive guidance tailored to your situation.
This isn't a formality. Ipamorelin can affect glucose metabolism and may interact with other hormonal therapies. A proper intake covers these bases before you start.
Step 2: Understand Ipamorelin Dosage Ranges
Dosing in clinical and research contexts varies. These are the ranges referenced in preclinical and observational literature — your provider determines the appropriate dose for you based on your goals and labs.
| Parameter | Commonly Referenced Range | Notes |
|---|---|---|
| Dose per injection | 100–300 mcg | Provider-set based on goals and labs |
| Injections per day | 1–3 | Most protocols use 1–2 daily injections |
| Route | Subcutaneous (SC) | Abdominal fat, thigh, or upper arm |
| Fasting state | Fasted preferred | Insulin attenuates GH pulse amplitude |
| Cycle length | 8–16 weeks typical | Break periods assessed by provider |
These ranges reflect published research literature — they are not prescriptive dosing instructions. Actual dose is subject to medical approval by a licensed provider after reviewing your full health profile.
Step 3: Choose Your Injection Timing
Timing matters with GH secretagogues. Insulin suppresses GH release, so injecting in a fasted or low-insulin state allows ipamorelin to generate a cleaner pulse. The original ipamorelin characterization studies confirmed its selectivity for GH release over cortisol and prolactin at physiological doses (Raun et al., Eur J Endocrinol 1998).
Common timing windows in research protocols:
- Before sleep (most common): Aligns with the body's largest natural GH pulse during slow-wave sleep. Bedtime is naturally fasted. This is the most consistently referenced timing in observational use.
- Fasted morning (pre-workout): Works if you train in the morning and can inject 15–30 minutes before. Avoid eating for 40–60 minutes after to preserve the pulse.
- Mid-afternoon (for 2x/day protocols): Typically paired with a before-bed injection. Should be at least 3 hours after your last meal.
Research on GH secretion during sleep shows the largest daily pulse accounts for 50–70% of total daily GH output — confirming why bedtime injection is the most studied timing window (Leproult & Van Cauter, JAMA 2011).
Do not inject within 2 hours of a carbohydrate-heavy meal. Elevated insulin blunts the GH response significantly.
Step 4: Prepare and Inject Correctly
Ipamorelin is typically supplied as a lyophilized (freeze-dried) powder that you reconstitute with bacteriostatic water. Proper preparation affects both safety and efficacy.
- Wash hands thoroughly. Wipe vial tops with an alcohol swab before drawing.
- Draw the appropriate volume of bacteriostatic water per your provider's instructions. Inject slowly along the side of the vial — don't spray directly onto the powder.
- Gently swirl until dissolved. Never shake — shaking degrades peptide integrity.
- Draw the prescribed dose into a fresh insulin syringe (typically 0.5 mL or 1 mL, 28–31 gauge).
- Wipe the injection site with an alcohol swab. Let it dry completely before injecting.
- Pinch the skin, insert the needle at a 45-degree angle into subcutaneous fat, and inject slowly.
- Dispose of needles in a proper sharps container immediately after use.
Rotate injection sites each time to avoid lipodystrophy. Store reconstituted peptide refrigerated and use within 28–30 days of reconstitution.
Step 5: Know What Ipamorelin Targets
Ipamorelin's selectivity is one of its distinguishing features. Unlike some GH secretagogues, it doesn't meaningfully raise cortisol or prolactin at typical doses — a profile that made it a focus of early GHS research.
What preclinical and early-stage human research links ipamorelin to:
- Increased GH pulse amplitude
- Elevated IGF-1 downstream of GH increase
- Potential effects on lean mass maintenance
- Sleep quality improvements via GH-timing alignment
- Bone density markers in animal models
What ipamorelin is not: a fat burner, a testosterone booster, or an approved treatment for any medical condition. These applications require separate clinical evaluation. All compounded peptides are subject to medical approval by a licensed provider.
Considering adding ipamorelin to your protocol? Submit your intake at TelosRX for an asynchronous provider review. Our clinical team evaluates each case individually.
Step 6: Stack Considerations (CJC-1295 and Others)
Ipamorelin is frequently used alongside CJC-1295 — a GHRH analog that extends the GH pulse that ipamorelin initiates. The combination targets two different points in the GH release pathway: GHRH stimulation (CJC-1295) plus GH secretagogue receptor activation (ipamorelin).
See our CJC-1295 and ipamorelin stack research guide for a full breakdown of how the combination works.
Stacking decisions — whether to combine, at what ratios, and for how long — are provider decisions. All combinations are subject to medical approval by a licensed provider after reviewing your complete health profile.
Step 7: Monitor and Adjust
Ipamorelin protocols aren't set-and-forget. Blood work — particularly IGF-1 levels — is a useful objective marker of GH axis activity. Your provider may recommend checking IGF-1 before and during a cycle to assess whether the protocol is generating meaningful GH stimulation and to keep levels within a physiologically appropriate range.
Watch for:
- Water retention or joint aches (signs of GH excess — uncommon but possible at high doses)
- Injection site issues: lumps, prolonged redness, or unusual pain
- Disrupted glucose tolerance (particularly relevant for people with insulin resistance)
Report any of these to your provider through the TelosRX portal. Protocol adjustments are handled asynchronously — no phone tag or scheduled visits required.
Frequently Asked Questions
How long does ipamorelin take to work?
Ipamorelin stimulates GH pulses immediately after injection, but tangible changes in body composition, sleep quality, or recovery typically take 4–8 weeks of consistent use. IGF-1 changes are usually detectable in lab work within 4–6 weeks at adequate dosing, providing an objective measure of GH axis response.
Can I use ipamorelin without stacking it with CJC-1295?
Yes. Ipamorelin has its own GH-stimulating mechanism and can be used as a standalone peptide. The CJC-1295 stack amplifies and extends the GH pulse, but it isn't required to start. Your provider will recommend an approach based on your goals and health profile — subject to medical approval by a licensed provider.
What's the best time to inject ipamorelin?
Before sleep is the most commonly referenced timing in observational protocols. This aligns with the body's natural peak GH pulse during slow-wave sleep and is naturally fasted. Morning pre-workout injection is an alternative for single daily injections. Avoid injecting within 2 hours of a carbohydrate-rich meal in either case.
Is ipamorelin safe for long-term use?
Long-term human safety data for ipamorelin is limited — most research comes from preclinical studies. Periodic cycling (8–16 weeks on, followed by a break) is the approach commonly referenced in clinical protocols to avoid potential pituitary desensitization. All long-term use decisions are subject to medical approval by a licensed provider with ongoing lab monitoring.
What does ipamorelin feel like?
Some people report improved sleep depth, mild warmth at the injection site, and occasional water retention in the first few weeks. Many report no acute sensation at all. The effects are subtle and build over weeks, not hours. Anyone experiencing unusual or pronounced reactions should contact their provider through the TelosRX platform promptly.
Is ipamorelin FDA-approved?
No. Ipamorelin is not FDA-approved for any indication. It's a compounded research peptide available through licensed pharmacies operating under federal compounding regulations, following evaluation and approval by a licensed provider. It's not available over the counter.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.